HomeComparePG vs FISV

PG vs FISV: Dividend Comparison 2026

PG yields 2.92% · FISV yields 3.67%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PG wins by $26.1K in total portfolio value· pulled ahead in Year 3
10 years
PG
Procter & Gamble
● Live price
2.92%
Share price
$144.73
Annual div
$4.23
5Y div CAGR
31.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.4K
Annual income
$9,955.44
Full PG calculator →
FISV
FISV
● Live price
3.67%
Share price
$54.53
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$464.28
Full FISV calculator →

Portfolio growth — PG vs FISV

📍 PG pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPGFISV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PG + FISV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PG pays
FISV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PG
Annual income on $10K today (after 15% tax)
$248.27/yr
After 10yr DRIP, annual income (after tax)
$8,462.12/yr
FISV
Annual income on $10K today (after 15% tax)
$311.75/yr
After 10yr DRIP, annual income (after tax)
$394.64/yr
At 15% tax rate, PG beats the other by $8,067.49/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PG + FISV for your $10,000?

PG: 50%FISV: 50%
100% FISV50/50100% PG
Portfolio after 10yr
$38.4K
Annual income
$5,209.86/yr
Blended yield
13.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FISV right now

PG
Analyst Ratings
29
Buy
22
Hold
1
Sell
Consensus: Buy
Price Target
$167.67
+15.9% upside vs current
Range: $150.00 — $179.00
Altman Z
5.3
Piotroski
4/9
FISV
Analyst Ratings
36
Buy
24
Hold
Consensus: Buy
Price Target
$104.18
+91.1% upside vs current
Range: $62.00 — $180.00
Altman Z
0.8
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PG buys
9
FISV buys
0
PoliticianChamberTickerTypeAmountDate
John Boozman🏛 Senate$PG▼ Sell$1,001 - $15,0002026-02-26
David Taylor🏢 House$PG▼ Sell$1,001 - $15,0002026-02-26
Lloyd Doggett🏢 House$PG▲ Buy$1,001 - $15,0002026-02-17
David Taylor🏢 House$PG▲ Buy$1,001 - $15,0002026-02-09
Julia Letlow🏢 House$PG▲ Buy$1,001 - $15,0002026-02-02
David Taylor🏢 House$PG▼ Sell$1,001 - $15,0002026-01-29
David Taylor🏢 House$PG▲ Buy$1,001 - $15,0002026-01-09
Gilbert Cisneros🏢 House$PG▼ Sell$1,001 - $15,0002025-12-24
Julie Johnson🏢 House$PG▼ Sell$1,001 - $15,0002025-12-18
Ed Case🏢 House$PG▼ Sell$1,001 - $15,0002025-12-01
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPGFISV
Forward yield2.92%3.67%
Annual dividend / share$4.23$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR31.1%0%
Portfolio after 10y$51.4K$25.4K
Annual income after 10y$9,955.44$464.28
Total dividends collected$29.3K$4.2K
Payment frequencyquarterlyquarterly
SectorConsumer StaplesStock
Analyst consensusBuyBuy
Analyst price target$167.67$104.18

Year-by-year: PG vs FISV ($10,000, DRIP)

YearPG PortfolioPG Income/yrFISV PortfolioFISV Income/yrGap
1$11,003$382.92$11,067$366.77$64.00FISV
2$12,205$520.11$12,221$379.34$16.00FISV
3← crossover$13,674$712.22$13,468$391.49+$206.00PG
4$15,507$985.02$14,814$403.22+$693.00PG
5$17,847$1,378.96$16,265$414.50+$1.6KPG
6$20,913$1,959.19$17,829$425.34+$3.1KPG
7$25,044$2,834.00$19,513$435.73+$5.5KPG
8$30,786$4,189.46$21,324$445.68+$9.5KPG
9$39,052$6,357.54$23,272$455.20+$15.8KPG
10$51,429$9,955.44$25,366$464.28+$26.1KPG

PG vs FISV: Complete Analysis 2026

PGConsumer Staples

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands. The Grooming segment provides shave care products and appliances under the Braun, Gillette, and Venus brand names. The Health Care segment offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brand names; and gastrointestinal, rapid diagnostics, respiratory, vitamins/minerals/supplements, pain relief, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. The Fabric & Home Care segment provides fabric enhancers, laundry additives, and laundry detergents under the Ariel, Downy, Gain, and Tide brands; and air care, dish care, P&G professional, and surface care products under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. The Baby, Feminine & Family Care segment offers baby wipes, taped diapers, and pants under the Luvs and Pampers brands; adult incontinence and feminine care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. The company sells its products primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores, high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.

Full PG Calculator →

FISVStock

Fiserv, Inc., together with its subsidiaries, provides payment and financial services technology worldwide. The company operates through Acceptance, Fintech, and Payments segments. The Acceptance segment provides point-of-sale merchant acquiring and digital commerce services; mobile payment services; security and fraud protection products; Carat, an omnichannel commerce solution; Clover, a cloud-based point-of-sale and business management platform; and Clover Connect, an independent software vendors platform. This segment distributes through various channels, including direct sales teams, strategic partnerships with agent sales forces, independent software vendors, financial institutions, and other strategic partners. The Fintech segment offers customer deposit and loan accounts, as well as manages an institution's general ledger and central information files. This segment also provides digital banking, financial and risk management, professional services and consulting, item processing and source capture, and other products and services. The Payments segment offers card transactions, such as debit, credit, and prepaid card processing and services; security and fraud protection products; card production; print services; and various network services, as well as non-card digital payment software and services, including bill payment, account-to-account transfers, person-to-person payments, electronic billing, and security and fraud protection products. It serves business, banks, credit unions, other financial institutions, merchants, and corporate clients. Fiserv, Inc. was incorporated in 1984 and is headquartered in Brookfield, Wisconsin.

Full FISV Calculator →
📬

Get this PG vs FISV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PG vs KOPG vs KMBPG vs CLPG vs CHDPG vs MOPG vs SCHDPG vs JEPIPG vs O

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.